CE, MOC, & Certificates

The 2017 Palliative and Supportive Care in Oncology Symposium seeks to promote the integration of palliative and supportive care practices, from diagnosis throughout the continuum of care, in order to better address the needs of patients and their families, by providing a forum for presentation and discussion of current research and best practices in the field utilizing a multi- and interdisciplinary approach. 

Accreditation and Designation Statement

In support of improving patient care, the American Society of Clinical Oncology is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

AMA Credit Designation Statement - Physicians

The American Society of Clinical Oncology designates this live activity for a maximum of 14.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ANCC Credit Designation Statement - Nurses

The maximum number of hours awarded for this CE activity is 14.75 contact hours

 

The American Association of Physician Assistants accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credits™ from organizations accredited by the ACCME or a recognized state medical society. PAs may receive a maximum of 14.75 Category 1 credits for completing this activity.

All other attendees are welcome to submit a request for a Certificate of Participation, through the submission process, which may enable nonphysicians to apply their participation toward re-licensure. Please note, however, that all final decisions regarding the awarding of credits will be made by the licensing organization to which the credits are submitted. 

Educational Needs Statement

Until recently, the term palliative care has been most frequently associated with end of life care. However, palliative care encompasses much more than end of life care. It provides an additional layer of support for both adults and children with a serious or life-threatening illness with a focus on relieving suffering and improving quality of life (QoL) for patients and their families. It provides patients of any disease stage with the best quality of life achievable regardless of prognosis. The focus is on helping people get relief from symptoms such as nausea, pain, fatigue, shortness of breath, etc., in addition to providing help with psychological, social and spiritual issues related to a disease of cancer or its treatment. The goal is to provide support to patients and their families from the time of diagnosis through the trajectory of their illness during any stage of the disease and in all care settings.  Despite palliative care being recognized as beneficial to patients and their families, a study of U.S. oncology trainees, residents and fellows, revealed that the perception of palliative care differed based on their specialty and clinical experience. However, despite the many benefits of palliative care, the United States does not have specific requirements for palliative care training in medical school and residency.

Target Audience

This symposium is designed for all members of the oncology team that are interested in the supportive and palliative care of patients with cancer: medical, radiation and surgical oncologists, nurses, physician assistants, residents and oncology fellows.

Learning Objectives

Upon participation in this activity, attendees will be better able to

  • Discuss the challenges of prognosis and palliative care management of patients with metastatic disease given the recent advances in cancer therapies and the ever-increasing immuno-oncology treatments;
  • Identify new opportunities supporting the integration of palliative care in the assessment and treatment of disease and treatment related symptoms, including issues of opioid use management;
  • Effectively manage the potential toxicities from cancer treatment; along with complexities from the use of combination treatment options between immunotherapy, chemotherapy and radiotherapy;
  • Identify barriers to implementing technological innovations to provide better patient support in the outpatient palliative care oncology setting;
  • Incorporate effective models of palliative care delivery for patients and their families in various clinical settings; and
  • Recognize opportunities by the oncology team to improve outcomes for older patients who are a vulnerable population in need of special considerations during the care trajectory.

Disclaimer and Unlabeled Usage Statement

The information presented is that of the contributing faculty and presenters and does not necessarily represent the views of ASCO, the Symposium Cosponsors, and/or any named company or organization providing financial support. Specific therapies discussed may not be approved and/or specified for use as indicated by the faculty or presenters. Therefore, before presenting any medication, please review the complete prescribing information including indications, contraindications, warnings, precautions, and adverse effects.

Commercial Supporters

ASCO and the Conquer Cancer Foundation gratefully acknowledge the following companies for their support of the2017 Palliative and Supportive Care in Oncology Symposium:

Pfizer Oncology